UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI C58

Assessment of Fetal Lung Maturity by the Lamellar Body Count; Approved Guideline

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 November 2011
Status: active
Page Count: 32
scope:

This document provides guidelines for the use of automated cell counting to enumerate lamellar bodies in amniotic fluid. It describes the different counting technologies used in automated cell counters as well as methods laboratorians can use to verify/validate the lamellar body count (LBC) test.

The intended users of this guideline are laboratory directors, medical technologists, laboratory supervisors, and pathologists, as well as in vitro diagnostic manufacturers involved in the development of devices and materials related to LBC testing.

This guideline does not provide guidance on how to establish the clinical utility of the LBC for fetal lung maturity (FLM).

Document History

CLSI C58
November 1, 2011
Assessment of Fetal Lung Maturity by the Lamellar Body Count; Approved Guideline
This document provides guidelines for the use of automated cell counting to enumerate lamellar bodies in amniotic fluid. It describes the different counting technologies used in automated cell...
November 1, 2011
Assessment of Fetal Lung Maturity by the Lamellar Body Count; Approved Guideline
This document provides guidelines for the use of automated cell counting to enumerate lamellar bodies in amniotic fluid. It describes the different counting technologies used in automated cell...

References

Advertisement